|Watch Shares of BIEL closely|
|By Staff and Wire Reports|
|Monday, 28 September 2009 16:49|
Make a note to keep an eye on shares of BioElectronics (OTC:BIEL) starting tomorrow morning, as the company has been working with the Pinksheets to remove the 'Caveat Emptor' notice which has prevented the stock from trading to it's maximum potential the last few weeks.
As we understand it, the company has submitted sustantial amounts of paperwork in order to get the trading exchange to have their status changed to "Fully Reporting" and they expect that the change may happen at any moment.
Shares would be expected to rise upon that development as they would upon any news regarding the company's application to the FDA. An approval decision from the agency is also expected any day.
BioElectronics Corporation (BioElectronics) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy.
Click on this link for all our past coverage about this momentum driven small cap stock.
UPDATE: At mid day on tuesday, the company announced its trading status update as The Pink Sheets Current Information Tier, under the ticker symbol BIEL. BioElectronics is continuing to provide full transparency to investors and broker-dealers following the guidelines provided by Pink OTC Markets, Inc.